Recent Insight into the Role of the PD-1/PD-L1 Pathway in Feto-Maternal Tolerance and Pregnancy

American Journal of Reproductive Immunology

Volumn 74, Issue 3, 2015, Pages 201-208

  Zhang, Yong Hong ^a   Tian, Mei ^a   Tang, Mao Xing ^a   Liu, Zhao Zhao ^a   Liao, Ai Hua ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Feto maternal interface; Immune tolerance; PD L1; Pregnancy; Programmed death 1

Indexed keywords

DRUG; PD L1 AGONIST; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 RECEPTOR; UNCLASSIFIED DRUG; CD274 PROTEIN, HUMAN; PDCD1 PROTEIN, HUMAN;

CELL INTERACTION; DECIDUA; FEMALE; FETO MATERNAL TOLERANCE; HOMEOSTASIS; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; MACROPHAGE; NONHUMAN; PHYSIOLOGY; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; RECURRENT PREGNANCY LOSS; REGULATORY T LYMPHOCYTE; REVIEW; STROMA CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; TH2 CELL; FETOMATERNAL TRANSFUSION; IMMUNOLOGY; METABOLISM; SIGNAL TRANSDUCTION;

ANTIGENS, CD274; FEMALE; HUMANS; IMMUNE TOLERANCE; MATERNAL-FETAL EXCHANGE; PREGNANCY; PROGRAMMED CELL DEATH 1 RECEPTOR; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY;

EID: 84937814461     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/aji.12365     Document Type: Review

References (39)

1. Shima T, Sasaki Y, Itoh M, Nakashima A, Ishii N, Sugamura K, Saito S: Regulatory T cells are necessary for implantation and maintenance of early pregnancy but not late pregnancy in allogeneic mice. J Reprod Immunol 2010; 85:121-129.
2. Lee SK, Kim JY, Hur SE, Kim CJ, Na BJ, Lee M, Gilman-Sachs A, Kwak-Kim J: An imbalance in interleukin-17-producing T and Foxp3(+) regulatory T cells in women with idiopathic recurrent pregnancy loss. Hum Reprod 2011; 26:2964-2971.
3. Darmochwal-Kolarz D, Kludka-Sternik M, Tabarkiewicz J, Kolarz B, Rolinski J, Leszczynska-Gorzelak B, Oleszczuk J: The predominance of Th17 lymphocytes and decreased number and function of Treg cells in preeclampsia. J Reprod Immunol 2012; 93:75-81.
4. Sharpe AH, Wherry EJ, Ahmed R, Freeman GJ: The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol 2007; 8:239-245.
5. Kaufmann DE, Walker BD: PD-1 and CTLA-4 inhibitory cosignaling pathways in HIV infection and the potential for therapeutic intervention. J Immunol 2009; 182:5891-5897.
6. Intlekofer AM, Thompson CB: At the bench: preclinical rationale for CTLA-4 and PD-1 blockade as cancer immunotherapy. J Leukoc Biol 2013; 94:25-39.
7. Driessens G, Kline J, Gajewski TF: Costimulatory and coinhibitory receptors in anti-tumor immunity. Immunol Rev 2009; 229:126-144.
8. Mueller DL, Jenkins MK, Schwartz RH: Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu Rev Immunol 1989; 7:445-480.
9. Francisco LM, Sage PT, Sharpe AH: The PD-1 pathway in tolerance and autoimmunity. Immunol Rev 2010; 236:219-242.
10. Zhang X, Schwartz JC, Guo X, Bhatia S, Cao E, Lorenz M, Cammer M, Chen L, Zhang ZY, Edidin MA, Nathenson SG, Almo SC: Structural and functional analysis of the costimulatory receptor programmed death-1. Immunity 2004; 20:337-347.
11. Keir ME, Butte MJ, Freeman GJ, Sharpe AH: PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol 2008; 26:677-704.
12. Kinter AL, Godbout EJ, McNally JP, Sereti I, Roby GA, O'Shea MA, Fauci AS: The common gamma-chain cytokines IL-2, IL-7, IL-15, and IL-21 induce the expression of programmed death-1 and its ligands. J Immunol 2008; 181:6738-6746.
13. Parry RV, Chemnitz JM, Frauwirth KA, Lanfranco AR, Braunstein I, Kobayashi SV, Linsley PS, Thompson CB, Riley JL: CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol Cell Biol 2005; 25:9543-9553.
14. Fife BT, Pauken KE, Eagar TN, Obu T, Wu J, Tang Q, Azuma M, Krummel MF, Bluestone JA: Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal. Nat Immunol 2009; 10:1185-1192.
15. Gianchecchi E, Delfino DV, Fierabracci A: Recent insights into the role of the PD-1/PD-L1 pathway in immunological tolerance and autoimmunity. Autoimmun Rev 2013; 12:1091-1100.
16. Fife BT, Guleria I, Gubbels Bupp M, Eagar TN, Tang Q, Bour-Jordan H, Yagita H, Azuma M, Sayegh MH, Bluestone JA: Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway. J Exp Med 2006; 203:2737-2747.
17. Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, McGrady G, Wahl SM: Conversion of peripheral CD4 + CD25- naive T cells to CD4 + CD25 + regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003; 198:1875-1886.
18. Rubtsov YP, Rudensky AY: TGFbeta signalling in control of T-cell-mediated self-reactivity. Nat Rev Immunol 2007; 7:443-453.
19. Francisco LM, Salinas VH, Brown KE, Vanguri VK, Freeman GJ, Kuchroo VK, Sharpe AH: PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J Exp Med 2009; 206:3015-3029.
20. D'Addio F, Riella LV, Mfarrej BG, Chabtini L, Adams LT, Yeung M, Yagita H, Azuma M, Sayegh MH, Guleria I: The link between the PDL1 costimulatory pathway and Th17 in fetomaternal tolerance. J Immunol 2011; 187:4530-4541.
21. Amarnath S, Mangus CW, Wang JC, Wei F, He A, Kapoor V, Foley JE, Massey PR, Felizardo TC, Riley JL, Levine BL, June CH, Medin JA, Fowler DH: The PDL1-PD1 axis converts human TH1 cells into regulatory T cells. Sci Transl Med 2011; 3:111-120.
22. Taglauer ES, Trikhacheva AS, Slusser JG, Petroff MG: Expression and function of PDCD1 at the human maternal-fetal interface. Biol Reprod 2008; 79:562-569.
23. Nagamatsu T, Schust DJ, Sugimoto J, Barrier BF: Human decidual stromal cells suppress cytokine secretion by allogenic CD4 + T cells via PD-1 ligand interactions. Hum Reprod 2009; 24:3160-3171.
24. Holets LM, Hunt JS, Petroff MG: Trophoblast CD274 (B7-H1) is differentially expressed across gestation: influence of oxygen concentration. Biol Reprod 2006; 74:352-358.
25. Petroff MG, Perchellet A: B7 family molecules as regulators of the maternal immune system in pregnancy. Am J Reprod Immunol 2010; 63:506-519.
26. Trundley A, Gardner L, Northfield J, Chang C, Moffett A: Methods for isolation of cells from the human fetal-maternal interface. Methods Mol Med 2006; 122:109-122.
27. Sayama S, Nagamatsu T, Schust DJ, Itaoka N, Ichikawa M, Kawana K, Yamashita T, Kozuma S, Fujii T: Human decidual macrophages suppress IFN-gamma production by T cells through costimulatory B7-H1:PD-1 signaling in early pregnancy. J Reprod Immunol 2013; 100:109-117.
28. Saito S, Nakashima A, Shima T, Ito M: Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am J Reprod Immunol 2010; 63:601-610.
29. Guleria I, Khosroshahi A, Ansari MJ, Habicht A, Azuma M, Yagita H, Noelle RJ, Coyle A, Mellor AL, Khoury SJ, Sayegh MH: A critical role for the programmed death ligand 1 in fetomaternal tolerance. J Exp Med 2005; 202:231-237.
30. Shepard MT, Bonney EA: PD-1 regulates T cell proliferation in a tissue and subset-specific manner during normal mouse pregnancy. Immunol Invest 2013; 42:385-408.
31. Habicht A, Dada S, Jurewicz M, Fife BT, Yagita H, Azuma M, Sayegh MH, Guleria I: A link between PDL1 and T regulatory cells in fetomaternal tolerance. J Immunol 2007; 179:5211-5219.
32. Wafula PO, Teles A, Schumacher A, Pohl K, Yagita H, Volk HD, Zenclussen AC: PD-1 but not CTLA-4 blockage abrogates the protective effect of regulatory T cells in a pregnancy murine model. Am J Reprod Immunol 2009; 62:283-292.
33. Grozdics E, Berta L, Bajnok A, Veres G, Ilisz I, Klivenyi P, Rigo J Jr, Vecsei L, Tulassay T, Toldi G: B7 costimulation and intracellular indoleamine-2, 3-dioxygenase (IDO) expression in peripheral blood of healthy pregnant and non-pregnant women. BMC Pregnancy Childbirth 2014; 14:306-314.
34. Toldi G, Vasarhelyi B, Biro E, Fugedi G, Rigo J Jr: Molvarec A: B7 costimulation and intracellular indoleamine-2, 3-dioxygenase expression in peripheral blood of healthy pregnant and pre-eclamptic women. Am J Reprod Immunol 2013; 69:264-271.
35. Liu Y, Zhao M, Xu X, Liu X, Zhang H, Jiang Y, Zhang L, Hu X: Adoptive transfer of treg cells counters adverse effects of Toxoplasma gondii infection on pregnancy. J Infect Dis 2014; 210:1435-1443.
36. Pardoll DM: The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 2012; 12:252-264.
37. Roncarolo MG, Battaglia M: Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat Rev Immunol 2007; 7:585-598.
38. Yang XO, Nurieva R, Martinez GJ, Kang HS, Chung Y, Pappu BP, Shah B, Chang SH, Schluns KS, Watowich SS, Feng XH, Jetten AM, Dong C: Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 2008; 29:44-56.
39. Joetham A, Matsubara S, Okamoto M, Takeda K, Miyahara N, Dakhama A, Gelfand EW: Plasticity of regulatory T cells: subversion of suppressive function and conversion to enhancement of lung allergic responses. J Immunol 2008; 180:7117-7124.